Table 3.
Adverse events in bisoprolol and placebo groups.
| Baseline characteristics | Bisoprolol (N = 57) | Placebo (N = 55) | P value | 
|---|---|---|---|
| Bronchospasm | 1 (1.8%) | 5 (9.1%) | 0.110 | 
| Heart failure | 2 (3.5%) | 4 (7.3%) | 0.434 | 
| Atrial fibrillation | 2 (3.5%) | 2 (3.6%) | 1.000 | 
| Postoperative stroke | 0 (0%) | 0 (0%) | |
| Postoperative sepsis | 4 (7.0%) | 4 (7.3%) | 1.000 | 
| Postoperative myocardial infarction | 4 (7.0%) | 2 (3.6%) | 0.679 | 
| Intraoperative hypotension | 40 (72.7%) | 26 (49.1%) | 0.017 | 
| Postoperative hypotension | 10 (17.5%) | 14 (25.5%) | 0.361 | 
| Postoperative bradycardia | 3 (5.3%) | 2 (3.6%) | 1.000 |